Webinar: How do I live well with Advanced Cancer?
There are many terms used to describe cancer that has moved beyond early stages, including secondary, metastatic, advanced and progressive cancer. Some health professionals don’t use a particular name, however, we will use the term advanced cancer.
Regardless of the word used, it’s confronting to hear that the cancer has spread or come back. But what happens when you are living with your advanced cancer? How do you deal with the everyday when you don’t know what the future holds?
In this webinar, we look at the way you can manage your daily routine and communications with friends and family so that you can live well with advanced cancer. We will also provide information for Health Professionals to assist them to holistically support people living with advanced cancer.
Panellists
Dr Diana Adams
Diana is a practising Senior Staff Specialist Medical Oncologist at the Macarthur Cancer Therapy Centre. She represents Clinical Oncology on the Executive Committee of the COSA Exercise and Cancer Group promoting Exercise in Cancer Care. She is heavily involved in Cancer Survivorship education and promoting the need to address both primary and secondary in obesity driven cancers. Approximately 70% of Diana’s patients are advanced where she uses targeted, endocrine, immunotherapy and chemotherapy. She is well versed in treating a wide range of cancers in a wide range of ages.
Associate Professor Craig Gedye
Craig Gedye is a medical oncologist and cancer researcher. He works for people with melanoma, brain, prostate, bladder and kidney cancers at the Calvary Mater Newcastle, is the Clinical Research Director at the NSW Health Statewide Biobank, and the Director of HMRI Clinical Trials. His research in the School of Medicine and Public Health at the University of Newcastle focuses on complexity and heterogeneity in cancer – why are cancers different between different people; why are cancers cells different to each other; what does this mean for each person’s treatment? Craig is leading several national cancer clinical trials for the ANZUP and COGNO trials groups and is Chair of the ANZUP Cancer Trials Renal Cancer Subcommittee.
Ian Cant
Ian is a father of five from Newcastle who was diagnosed with a 66mm tumour on the top of his left lung in March 2016. A PET scan revealed that Ian in fact had between 20 and 30 tumours on both his lungs, two on top of his abdomen and on the back of his brain. Thankfully an immunotherapy drug called Keytruda was introduced to the Pharmaceutical Benefits Scheme which worked completely for Ian. He knows he is one of the lucky ones and now the retired detective and builder dedicates himself to raising awareness for all aspects of advanced cancer.